Arrowhead Pharmaceuticals, Inc. (ARWR)
64.19
-0.60
(-0.93%)
USD |
NASDAQ |
Oct 02, 16:00
64.06
-0.13
(-0.20%)
After-Hours: 20:00
Arrowhead Pharmaceuticals Profit Margin (Quarterly) : -237.8% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -237.8% |
| March 31, 2026 | -186.6% |
| December 31, 2025 | 10.70% |
| September 30, 2025 | 6.29% |
| June 30, 2025 | -643.4% |
| March 31, 2025 | 67.78% |
| December 31, 2024 | -7.01K% |
| September 30, 2024 | |
| June 30, 2024 | |
| March 31, 2024 | |
| December 31, 2023 | -3.81K% |
| September 30, 2023 | -689.7% |
| June 30, 2023 | -658.0% |
| March 31, 2023 | 32.60% |
| December 31, 2022 | -66.85% |
| September 30, 2022 | -272.2% |
| June 30, 2022 | -222.3% |
| March 31, 2022 | 29.23% |
| December 31, 2021 | -229.1% |
| September 30, 2021 | -165.5% |
| June 30, 2021 | -65.21% |
| March 31, 2021 | -81.73% |
| December 31, 2020 | -97.32% |
| September 30, 2020 | -634.5% |
| June 30, 2020 | -49.72% |
| Date | Value |
|---|---|
| March 31, 2020 | -84.30% |
| December 31, 2019 | -9.08% |
| September 30, 2019 | 27.04% |
| June 30, 2019 | 47.63% |
| March 31, 2019 | 49.63% |
| December 31, 2018 | 34.73% |
| September 30, 2018 | -95.61% |
| June 30, 2018 | -2.15K% |
| March 31, 2018 | -2.29K% |
| December 31, 2017 | -376.1% |
| September 30, 2017 | -123.2% |
| June 30, 2017 | -59.08% |
| March 31, 2017 | -67.25% |
| December 31, 2016 | -276.9% |
| September 30, 2016 | -71.22K% |
| June 30, 2016 | -49.04K% |
| March 31, 2016 | -47.52K% |
| December 31, 2015 | -43.98K% |
| September 30, 2015 | -56.49K% |
| June 30, 2015 | -12.87K% |
| March 31, 2015 | -65.49K% |
| December 31, 2014 | -13.22K% |
| September 30, 2014 | -51.21K% |
| June 30, 2014 | -26.54K% |
| March 31, 2014 | -31.92K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Sarepta Therapeutics, Inc. | -1.22% |
| Moderna, Inc. | -539.3% |
| Revolution Medicines, Inc. | -- |
| Intellia Therapeutics, Inc. | -1.39K% |
| Denali Therapeutics, Inc. | -3.54K% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -51.33% |
| Return on Assets | -15.43% |
| Return on Invested Capital | -18.06% |
| Gross Profit Margin (Quarterly) | 91.15% |
| Operating Margin (Quarterly) | -226.0% |
| Return on Net Operating Assets | -54.00% |